141 related articles for article (PubMed ID: 9924215)
1. Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis, and osteochondrosis.
Brama PA; TeKoppele JM; Beekman B; van Weeren PR; Barneveld A
Ann Rheum Dis; 1998 Nov; 57(11):697-9. PubMed ID: 9924215
[TBL] [Abstract][Full Text] [Related]
2. Influence of development and joint pathology on stromelysin enzyme activity in equine synovial fluid.
Brama PA; TeKoppele JM; Beekman B; van El B; Barneveld A; van Weeren PR
Ann Rheum Dis; 2000 Feb; 59(2):155-7. PubMed ID: 10666176
[TBL] [Abstract][Full Text] [Related]
3. Collagenase-1 (MMP-1) activity in equine synovial fluid: influence of age, joint pathology, exercise and repeated arthrocentesis.
Brama PA; van den Boom R; DeGroott J; Kiers GH; van Weeren PR
Equine Vet J; 2004 Jan; 36(1):34-40. PubMed ID: 14756369
[TBL] [Abstract][Full Text] [Related]
4. Relationship between synovial fluid levels of glycosaminoglycans, hydroxyproline and general MMP activity and the presence and severity of articular cartilage change on the proximal articular surface of P1.
van den Boom R; van der Harst MR; Brommer H; Brama PA; Barneveld A; van Weeren PR; DeGroot J
Equine Vet J; 2005 Jan; 37(1):19-25. PubMed ID: 15651729
[TBL] [Abstract][Full Text] [Related]
5. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays.
Fietz S; Einspanier R; Hoppner S; Hertsch B; Bondzio A
Equine Vet J; 2008 May; 40(3):266-71. PubMed ID: 18089467
[TBL] [Abstract][Full Text] [Related]
6. Assessment of synovial fluid biomarkers in healthy foals and in foals with tarsocrural osteochondrosis.
de Grauw JC; Donabédian M; van de Lest CH; Perona G; Robert C; Lepage O; Martin-Rosset W; van Weeren PR
Vet J; 2011 Dec; 190(3):390-5. PubMed ID: 21216637
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the effects of age and joint disease on hydroxyproline and glycosaminoglycan concentrations in synovial fluid from the metacarpophalangeal joint of horses.
van den Boom R; Brama PA; Kiers GH; de Groot J; van Weeren PR
Am J Vet Res; 2004 Mar; 65(3):296-302. PubMed ID: 15027675
[TBL] [Abstract][Full Text] [Related]
8. The influence of repeated arthrocentesis and exercise on matrix metalloproteinase and tumour necrosis factor alpha activities in normal equine joints.
van den Boom R; Brama PA; Kiers GH; DeGroot J; Barneveld A; van Weeren RR
Equine Vet J; 2004 Mar; 36(2):155-9. PubMed ID: 15038439
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases 2 and 9 in equine synovial fluids.
Clegg PD; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059
[TBL] [Abstract][Full Text] [Related]
10. MT3-MMP (MMP-16) is downregulated by in vitro cytokine stimulation of cartilage, but unaltered in naturally occurring equine osteoarthritis and osteochondrosis.
Garvican ER; Vaughan-Thomas A; Redmond C; Clegg PD
Connect Tissue Res; 2008; 49(2):62-7. PubMed ID: 18382891
[TBL] [Abstract][Full Text] [Related]
11. Gambling on putative biomarkers of osteoarthritis and osteochondrosis by equine synovial fluid proteomics.
Chiaradia E; Pepe M; Tartaglia M; Scoppetta F; D'Ambrosio C; Renzone G; Avellini L; Moriconi F; Gaiti A; Bertuglia A; Beccati F; Scaloni A
J Proteomics; 2012 Jul; 75(14):4478-93. PubMed ID: 22361695
[TBL] [Abstract][Full Text] [Related]
12. Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses.
Trumble TN; Trotter GW; Oxford JR; McIlwraith CW; Cammarata S; Goodnight JL; Billinghurst RC; Frisbie DD
Am J Vet Res; 2001 Sep; 62(9):1467-77. PubMed ID: 11560279
[TBL] [Abstract][Full Text] [Related]
13. Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations.
Jouglin M; Robert C; Valette JP; Gavard F; Quintin-Colonna F; Denoix JM
Vet Res; 2000; 31(5):507-15. PubMed ID: 11050746
[TBL] [Abstract][Full Text] [Related]
14. Gelatinase activity in synovial fluid and synovium obtained from healthy and osteoarthritic joints of dogs.
Volk SW; Kapatkin AS; Haskins ME; Walton RM; D'Angelo M
Am J Vet Res; 2003 Oct; 64(10):1225-33. PubMed ID: 14596458
[TBL] [Abstract][Full Text] [Related]
15. Identification of infrared absorption spectral characteristics of synovial fluid of horses with osteochondrosis of the tarsocrural joint.
Vijarnsorn M; Riley CB; Ryan DA; Rose PL; Shaw RA
Am J Vet Res; 2007 May; 68(5):517-23. PubMed ID: 17472451
[TBL] [Abstract][Full Text] [Related]
16. The influence of birth weight, rate of weight gain and final achieved height and sex on the development of osteochondrotic lesions in a population of genetically predisposed Warmblood foals.
van Weeren PR; Sloet van Oldruitenborgh-Ooste ; Barneveld A
Equine Vet J Suppl; 1999 Nov; (31):26-30. PubMed ID: 10999657
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of lubricin in synovial fluid from horses with osteoarthritis.
Svala E; Jin C; Rüetschi U; Ekman S; Lindahl A; Karlsson NG; Skiöldebrand E
Equine Vet J; 2017 Jan; 49(1):116-123. PubMed ID: 26507102
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-2 and -9 are activated in joint diseases.
Clegg PD; Carter SD
Equine Vet J; 1999 Jul; 31(4):324-30. PubMed ID: 10454092
[TBL] [Abstract][Full Text] [Related]
20. The effect of drugs commonly used in the treatment of equine articular disorders on the activity of equine matrix metalloproteinase-2 and 9.
Clegg PD; Jones MD; Carter SD
J Vet Pharmacol Ther; 1998 Oct; 21(5):406-13. PubMed ID: 9811443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
